Related Experiment Video
Updated: Aug 1, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Parathyroidectomy: new criteria for evaluating outcome
G L Irvin1, A S Molinari, D M Carneiro
1Department of Surgery, University of Miami/Jackson Memorial and Veterans Affairs Medical Centers, Florida, USA.
The American Surgeon
|December 22, 1999
Summary
Post-parathyroidectomy care requires updated biochemical monitoring. New criteria help identify patients with elevated parathyroid hormone (PTH) or calcium levels, indicating potential recurrence of hyperparathyroidism.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Successful parathyroidectomy improves symptoms in primary hyperparathyroidism patients.
- Evolving diagnostic methods for parathyroid hormone (PTH) and serum calcium necessitate revised postoperative outcome evaluation.
Purpose of the Study:
- To establish revised biochemical criteria for assessing long-term outcomes after parathyroidectomy.
- To identify patients at risk for recurrent hyperparathyroidism post-surgery.
Main Methods:
- A retrospective analysis of 271 patients following parathyroidectomy over an average of 6.3 years.
- Monitoring of serum calcium and intact parathyroid hormone (iPTH) levels.
Main Results:
- 15% of patients with normal postoperative calcium had elevated iPTH.
- Recurrent hyperparathyroidism was observed in 57% of patients with elevated calcium and iPTH.
- 5 patients experienced hypercalcemia with normal iPTH levels.
Conclusions:
- Annual monitoring of serum calcium and PTH is recommended for patients with successfully treated primary hyperparathyroidism.
- Elevated iPTH in normocalcemic patients warrants attention.
- These updated criteria aid in detecting late recurrence and managing hyperfunctioning parathyroid glands.
